# Safety and Pharmacokinetics of Single Intravenous Doses of Peginesatide in Healthy Volunteers

> **NCT00097747** · PHASE1 · COMPLETED · sponsor: **Affymax** · enrollment: 28 (actual)

## Conditions studied

- Anemia
- Chronic Kidney Disease
- Chronic Renal Failure
- Cancer

## Interventions

- **DRUG:** Placebo
- **DRUG:** peginesatide

## Key facts

- **NCT ID:** NCT00097747
- **Lead sponsor:** Affymax
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08
- **Primary completion:** 2005-01
- **Final completion:** 2005-01
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2012-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00097747

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00097747, "Safety and Pharmacokinetics of Single Intravenous Doses of Peginesatide in Healthy Volunteers". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00097747. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*